Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

DiversifyRx

Tirzepatide Compounding Update: FDA Reversal & What Pharmacies Need to Know! | Becoming A Pharmacy Badass

16 Apr 2025

Description

**Dr. Lisa Faast shares important news about tirzepatide compounding. After a shortage, the FDA reversed its decision and now allows pharmacies to compound and sell tirzepatide again. She covers the latest updates, suppliers like Lone Star Pharmaceuticals, BPI Labs, and PQ Pharma, and tips on staying compliant with state boards. Stay informed by joining the APC Alliance.** **Show Notes:** 1. **FDA Reversal on Tirzepatide Compounding** [0:00] 2. **Clarification from the FDA ** [2:51] 3. **Availability and Cost of Tirzepatide ** [5:09] 4. **State Regulations and Documentation** [6:31] 5. **Final Thoughts and Resources** [7:02] <br> **Websites Mentioned: https://lonestarpharmaceuticals.com/ https://bpilabs.com/ https://www.pqpharmacy.com/s/ https://diversifyrx.com/weekly-awesomeness-newsletter/ https://www.drlisafaast.com/ ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.